Computacenter - Director/PDMR Shareholding
Incorporated in
Registration number: 03110569
LEI: 549300XSXUZ1I19DB105
ISIN: GB00BV9FP302
(the 'Company')
The following notifications are made under article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by Directors of the Company, Persons Discharging Managerial Responsibilities ('PDMR') of the Company and/or Persons Closely Associated ('PCA') with the Directors and PDMRs.
On
This transaction represented approximately 0.52% of the total number of voting rights in the Company. Following this transaction, The Trust's beneficial holding is 6,818,383 Ordinary Shares, representing 6.41% of the total number of voting rights in the Company.
PDMR/PCA FCA Transaction Notification
1.
|
Details of Person Closely Associated with Person Discharging Managerial Responsibilities
|
||
|
|
|
|
2. |
Reason for the notification
|
||
2(a)
|
Position/Status |
Person Closely Associated with Peter Ogden - Non-Executive Director of
|
|
2(b)
|
Initial Notification/ Amendment
|
Initial Notification |
|
3.
|
Details of the issuer
|
||
3(a)
|
|
|
|
3(b)
|
LEI |
549300XSXUZ1I19DB105 |
|
4. |
Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted
|
||
4(a)
|
Description of the financial instrument
|
Ordinary shares of 7 5/9 pence in
ISIN: GB00BV9FP302
|
|
4(b)
|
Nature of Transaction
|
A sale of Ordinary Shares by
|
|
4(c)
|
Price(s) and Volume(s)
|
Price(s) (in GBP)
|
Volume(s) |
23.12 |
562,284 |
||
4(d)
|
Aggregated Information
Aggregated Volume and Price
|
23.12 |
562,284 |
4(e)
|
Date of the transaction
|
|
|
4(f)
|
Place of the transaction
|
XOFF |
Enquiries:
|
|
|
Company Secretary |
|
|
Address: |
Hatfield AL10 9TW |
|
|
Telephone: |
01707 631 000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the